SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442024
Filing Date
2013-11-14
Accepted
2013-11-14 15:36:08
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d601481d10q.htm 10-Q 215181
2 EX-10.1 d601481dex101.htm EX-10.1 27386
3 EX-31.1 d601481dex311.htm EX-31.1 7305
4 EX-31.2 d601481dex312.htm EX-31.2 7336
5 EX-32.1 d601481dex321.htm EX-32.1 6519
  Complete submission text file 0001193125-13-442024.txt   2559276

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qhoi-20130930.xml EX-101.INS 193852
7 XBRL TAXONOMY EXTENSION SCHEMA qhoi-20130930.xsd EX-101.SCH 38424
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qhoi-20130930_cal.xml EX-101.CAL 33273
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qhoi-20130930_def.xml EX-101.DEF 117326
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qhoi-20130930_lab.xml EX-101.LAB 474874
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qhoi-20130930_pre.xml EX-101.PRE 208432
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52062 | Film No.: 131219641
SIC: 2834 Pharmaceutical Preparations